US$ 20.16
glp-1 agonists and health coaching Frontiers Muscle loss and GLP-1R agonists
Description
Research indicates it helps regulate blood sugar, reduce inflammation, and support healthy weight management by improving overall metabolic function

Now, even when Im wrong, it feels like the decision is mine and that difference matters

Patients who were obese and took semaglutide were more than seven times more likely to develop NAION than those on other medications
I think that once Mounjaro is approved for weight loss at the end of 2023 this trend will gain steam in a significant way, which would likely reflect in Q2-Q3 2024 earnings for PHG, RMD etc

1,2 Effective post-overdose interventions remain limited: medications for opioid use disorder reduce repeat overdose risk substantially but reach only a small minority of survivors, and no widely used pharmacotherapy addresses the broader range of substances involved in overdose events

No extra nausea
